Alberta Investment Management Corp Acquires New Stake in Humana Inc. (NYSE:HUM)

Alberta Investment Management Corp acquired a new stake in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 23,840 shares of the insurance provider’s stock, valued at approximately $6,048,000.

A number of other large investors have also made changes to their positions in HUM. AMF Tjanstepension AB boosted its stake in shares of Humana by 166.8% during the third quarter. AMF Tjanstepension AB now owns 40,051 shares of the insurance provider’s stock valued at $12,686,000 after acquiring an additional 25,041 shares during the last quarter. Stratos Wealth Advisors LLC boosted its stake in shares of Humana by 125.3% during the third quarter. Stratos Wealth Advisors LLC now owns 1,302 shares of the insurance provider’s stock valued at $412,000 after acquiring an additional 724 shares during the last quarter. Raymond James & Associates boosted its stake in shares of Humana by 3.5% during the third quarter. Raymond James & Associates now owns 99,530 shares of the insurance provider’s stock valued at $31,525,000 after acquiring an additional 3,341 shares during the last quarter. Copeland Capital Management LLC boosted its stake in shares of Humana by 27.4% during the third quarter. Copeland Capital Management LLC now owns 809 shares of the insurance provider’s stock valued at $256,000 after acquiring an additional 174 shares during the last quarter. Finally, Sequoia Financial Advisors LLC boosted its stake in shares of Humana by 3.2% during the third quarter. Sequoia Financial Advisors LLC now owns 2,408 shares of the insurance provider’s stock valued at $763,000 after acquiring an additional 74 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.29% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on the company. TD Cowen raised their price target on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price target on shares of Humana in a research note on Wednesday, February 12th. Truist Financial raised their price target on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Finally, Morgan Stanley decreased their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Nineteen equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $285.68.

Humana Price Performance

Shares of HUM opened at $265.54 on Thursday. The firm has a market cap of $31.97 billion, a price-to-earnings ratio of 26.69, a PEG ratio of 1.91 and a beta of 0.56. The stock has a 50 day moving average of $269.80 and a 200-day moving average of $291.28. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46.

Humana (NYSE:HUM) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, analysts forecast that Humana Inc. will post 16.49 EPS for the current year.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.